Apricus Biosciences Launches Educational Video Series Focused On Its Newly Approved Erectile Dysfunction Drug, Vitaros(R)

SAN DIEGO--(BUSINESS WIRE)--Apricus Biosciences, Inc. (Nasdaq:APRI), based in San Diego, announced today that Dr. Bassam Damaj, Ph.D., Chairman, President and Chief Executive Officer, is now appearing in a series of online educational videos focused on its newly approved erectile dysfunction drug, Vitaros®, which was approved by Health Canada in November 2010. The video series can be seen on the company’s website. The company stated that the video series was created to provide answers to commonly asked questions about the newly approved drug, which is the first approved erectile dysfunction treatment in the western hemisphere that is applied topically.
MORE ON THIS TOPIC